Rose Kushner Award Winners Announced

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 10
Volume 4
Issue 10

BETHESDA, Md-The American Medical Writers Association (AMWA) has announced the winners of the 1995 Rose Kushner Awards for Writing Achievement in the Field of Breast Cancer, sponsored by the AMWA and Zeneca Pharmaceuticals.

BETHESDA, Md-The American Medical Writers Association (AMWA) hasannounced the winners of the 1995 Rose Kushner Awards for WritingAchievement in the Field of Breast Cancer, sponsored by the AMWAand Zeneca Pharmaceuticals.

  • Lay articles: Laurie Tarkan, How Daughters Face Their Mother'sBreast Cancer (McCall's), and Nicole Spelhaug, Breast Cancer:New Perspectives Can Replace Unrealistic Fears (supplement tothe Mayo Clinic Health Letter).
  • Scientific articles: Amy S. Langer and Karen Hassey Dow, TheBreast Cancer Advocacy Movement and Nursing (Oncology Nursing).
  • Scripts: Jane Glenn Haas, On-Line (The Orange Count News Channel).
  • Brochures and monographs: Aaron Rachel Rose, For Single WomenWith Breast Cancer (Y-ME National Breast Cancer Organization).

Articles in this issue
New Markers May Help Predict Course of Prostate Carcinoma
Needle Exchange Programs Lower HIV Risk: Panel
Computerized Database Could Lead to Improved Staging of Lung Cancer
Registry Analysis Shows Good Results Using Limited Lung Resections for Lung Ca Patients
Centocor Wellness Program Includes Mobile Mammography Van
Institute of the Future Urges US to Increase Spending on Basic R&D
Positron Emission Tomography (PET) May Prove a Useful Adjunct to CT in Detecting Early-Stage Pancreatic Cancers
Yeast-Derived GM-CSF (Leukine) Cleared for Use in Older AML Patients
Spiral CT Offers Better Detection of Disease, More Accurate Staging
New Colon Ca Agent Is Available in France
New Dual Antibiotic Effective Against Changing Hospital Flora
Network Readies Its Practice Guidelines
Symptom Distress, Including Pain, Predicts Lung Ca Survival
Chemo May Improve Quality of Life in Advanced Lung Cancer
No Increased Ovarian, Endometrial Cancer Risk With Short-Term Tamoxifen Therapy
Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table
Related Content
An increased TIL count in the breast tissue was associated with improved distant recurrence-free survival in patients with triple-negative breast cancer.

Survival Outcomes Improve With TIL Presence in TNBC

April 16th 2024
Article

An increased TIL count in the breast tissue was associated with improved distant recurrence-free survival in patients with triple-negative breast cancer.

Sarah Donahue, MPH, NP, speaks to the importance of communicating potential adverse effects associated with treatments such as CDK4/6 inhibitors to patients with breast cancer.

Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer

January 15th 2024
Podcast

Sarah Donahue, MPH, NP, speaks to the importance of communicating potential adverse effects associated with treatments such as CDK4/6 inhibitors to patients with breast cancer.

71 Utility of Performing Staging MRI in Breast Cancer Patients Over the Age of 75

71 Utility of Performing Staging MRI in Breast Cancer Patients Over the Age of 75

April 14th 2024
Article
HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer

HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer

January 8th 2024
Podcast

Tucatinib plus trastuzumab emtansine shows a progression-free survival improvement in HER2-positive breast cancer in the phase 3 HER2CLIMB-02 trial, says Sara A. Hurvitz, MD, FACP.

Oncologic outcomes from a real-world analysis appear to be comparable with those observed in the sentinel lymph node biopsy arm of the SOUND trial.

Real-World Data Support SLNB Omission in HR+ HER2– Breast Cancer

April 11th 2024
Article

Oncologic outcomes from a real-world analysis appear to be comparable with those observed in the sentinel lymph node biopsy arm of the SOUND trial.

The National Accreditation Program for Breast Centers looked at time intervals to see where delays occurred throughout the process for those with breast cancer.

Time to Screening/Treatment/Surgery is Underestimated at Breast Centers

April 11th 2024
Article

The National Accreditation Program for Breast Centers looked at time intervals to see where delays occurred throughout the process for those with breast cancer.